Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |